Panitumumab in Cetuximab Refractory KRAS Wild-Type Colorectal Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Massachusetts General Hospital.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborators:
Beth Israel Deaconess Medical Center
Dana-Farber Cancer Institute
Amgen
Information provided by:
Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00842257
First received: February 10, 2009
Last updated: May 3, 2010
Last verified: May 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: March 2011
  Estimated Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
No publications provided by Massachusetts General Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):